Cargando…

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease

Recent genome-wide association studies (GWAS) of late-onset Alzheimer’s disease (LOAD) have identified single nucleotide polymorphisms (SNPs) which show significant association at the well-known APOE locus and at nineteen additional loci. Among the functional, disease-associated variants at these lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Medway, Christopher W, Abdul-Hay, Samer, Mims, Tynickwa, Ma, Li, Bisceglio, Gina, Zou, Fanggeng, Pankratz, Shane, Sando, Sigrid B, Aasly, Jan O, Barcikowska, Maria, Siuda, Joanna, Wszolek, Zbigniew K, Ross, Owen A, Carrasquillo, Minerva, Dickson, Dennis W, Graff-Radford, Neill, Petersen, Ronald C, Ertekin-Taner, Nilüfer, Morgan, Kevin, Bu, Guojun, Younkin, Steven G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995879/
https://www.ncbi.nlm.nih.gov/pubmed/24607147
http://dx.doi.org/10.1186/1750-1326-9-11
_version_ 1782312946765922304
author Medway, Christopher W
Abdul-Hay, Samer
Mims, Tynickwa
Ma, Li
Bisceglio, Gina
Zou, Fanggeng
Pankratz, Shane
Sando, Sigrid B
Aasly, Jan O
Barcikowska, Maria
Siuda, Joanna
Wszolek, Zbigniew K
Ross, Owen A
Carrasquillo, Minerva
Dickson, Dennis W
Graff-Radford, Neill
Petersen, Ronald C
Ertekin-Taner, Nilüfer
Morgan, Kevin
Bu, Guojun
Younkin, Steven G
author_facet Medway, Christopher W
Abdul-Hay, Samer
Mims, Tynickwa
Ma, Li
Bisceglio, Gina
Zou, Fanggeng
Pankratz, Shane
Sando, Sigrid B
Aasly, Jan O
Barcikowska, Maria
Siuda, Joanna
Wszolek, Zbigniew K
Ross, Owen A
Carrasquillo, Minerva
Dickson, Dennis W
Graff-Radford, Neill
Petersen, Ronald C
Ertekin-Taner, Nilüfer
Morgan, Kevin
Bu, Guojun
Younkin, Steven G
author_sort Medway, Christopher W
collection PubMed
description Recent genome-wide association studies (GWAS) of late-onset Alzheimer’s disease (LOAD) have identified single nucleotide polymorphisms (SNPs) which show significant association at the well-known APOE locus and at nineteen additional loci. Among the functional, disease-associated variants at these loci, missense variants are particularly important because they can be readily investigated in model systems to search for novel therapeutic targets. It is now possible to perform a low-cost search for these “actionable” variants by genotyping the missense variants at known LOAD loci already cataloged on the Exome Variant Server (EVS). In this proof-of-principle study designed to explore the efficacy of this approach, we analyzed three rare EVS variants in APOE, p.L28P, p.R145C and p.V236E, in our case control series of 9114 subjects. p.R145C proved to be too rare to analyze effectively. The minor allele of p.L28P, which was in complete linkage disequilibrium (D’ = 1) with the far more common APOE ϵ4 allele, showed no association with LOAD (P = 0.75) independent of the APOE ϵ4 allele. p.V236E was significantly associated with a marked reduction in risk of LOAD (P = 7.5×10(−05); OR = 0.10, 0.03 to 0.45). The minor allele of p.V236E, which was in complete linkage disequilibrium (D’ = 1) with the common APOE ϵ3 allele, identifies a novel LOAD-associated haplotype (APOE ϵ3b) which is associated with decreased risk of LOAD independent of the more abundant APOE ϵ2, ϵ3 and ϵ4 haplotypes. Follow-up studies will be important to confirm the significance of this association and to better define its odds ratio. The ApoE p.V236E substitution is the first disease-associated change located in the lipid-binding, C-terminal domain of the protein. Thus our study (i) identifies a novel APOE missense variant which may profitably be studied to better understand how ApoE function may be modified to reduce risk of LOAD and (ii) indicates that analysis of protein-altering variants cataloged on the EVS can be a cost-effective way to identify actionable functional variants at recently discovered LOAD loci.
format Online
Article
Text
id pubmed-3995879
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39958792014-04-23 ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease Medway, Christopher W Abdul-Hay, Samer Mims, Tynickwa Ma, Li Bisceglio, Gina Zou, Fanggeng Pankratz, Shane Sando, Sigrid B Aasly, Jan O Barcikowska, Maria Siuda, Joanna Wszolek, Zbigniew K Ross, Owen A Carrasquillo, Minerva Dickson, Dennis W Graff-Radford, Neill Petersen, Ronald C Ertekin-Taner, Nilüfer Morgan, Kevin Bu, Guojun Younkin, Steven G Mol Neurodegener Short Report Recent genome-wide association studies (GWAS) of late-onset Alzheimer’s disease (LOAD) have identified single nucleotide polymorphisms (SNPs) which show significant association at the well-known APOE locus and at nineteen additional loci. Among the functional, disease-associated variants at these loci, missense variants are particularly important because they can be readily investigated in model systems to search for novel therapeutic targets. It is now possible to perform a low-cost search for these “actionable” variants by genotyping the missense variants at known LOAD loci already cataloged on the Exome Variant Server (EVS). In this proof-of-principle study designed to explore the efficacy of this approach, we analyzed three rare EVS variants in APOE, p.L28P, p.R145C and p.V236E, in our case control series of 9114 subjects. p.R145C proved to be too rare to analyze effectively. The minor allele of p.L28P, which was in complete linkage disequilibrium (D’ = 1) with the far more common APOE ϵ4 allele, showed no association with LOAD (P = 0.75) independent of the APOE ϵ4 allele. p.V236E was significantly associated with a marked reduction in risk of LOAD (P = 7.5×10(−05); OR = 0.10, 0.03 to 0.45). The minor allele of p.V236E, which was in complete linkage disequilibrium (D’ = 1) with the common APOE ϵ3 allele, identifies a novel LOAD-associated haplotype (APOE ϵ3b) which is associated with decreased risk of LOAD independent of the more abundant APOE ϵ2, ϵ3 and ϵ4 haplotypes. Follow-up studies will be important to confirm the significance of this association and to better define its odds ratio. The ApoE p.V236E substitution is the first disease-associated change located in the lipid-binding, C-terminal domain of the protein. Thus our study (i) identifies a novel APOE missense variant which may profitably be studied to better understand how ApoE function may be modified to reduce risk of LOAD and (ii) indicates that analysis of protein-altering variants cataloged on the EVS can be a cost-effective way to identify actionable functional variants at recently discovered LOAD loci. BioMed Central 2014-03-10 /pmc/articles/PMC3995879/ /pubmed/24607147 http://dx.doi.org/10.1186/1750-1326-9-11 Text en Copyright © 2014 Medway et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Medway, Christopher W
Abdul-Hay, Samer
Mims, Tynickwa
Ma, Li
Bisceglio, Gina
Zou, Fanggeng
Pankratz, Shane
Sando, Sigrid B
Aasly, Jan O
Barcikowska, Maria
Siuda, Joanna
Wszolek, Zbigniew K
Ross, Owen A
Carrasquillo, Minerva
Dickson, Dennis W
Graff-Radford, Neill
Petersen, Ronald C
Ertekin-Taner, Nilüfer
Morgan, Kevin
Bu, Guojun
Younkin, Steven G
ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
title ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
title_full ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
title_fullStr ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
title_full_unstemmed ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
title_short ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
title_sort apoe variant p.v236e is associated with markedly reduced risk of alzheimer’s disease
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995879/
https://www.ncbi.nlm.nih.gov/pubmed/24607147
http://dx.doi.org/10.1186/1750-1326-9-11
work_keys_str_mv AT medwaychristopherw apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT abdulhaysamer apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT mimstynickwa apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT mali apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT biscegliogina apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT zoufanggeng apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT pankratzshane apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT sandosigridb apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT aaslyjano apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT barcikowskamaria apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT siudajoanna apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT wszolekzbigniewk apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT rossowena apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT carrasquillominerva apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT dicksondennisw apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT graffradfordneill apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT petersenronaldc apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT ertekintanernilufer apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT morgankevin apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT buguojun apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease
AT younkinsteveng apoevariantpv236eisassociatedwithmarkedlyreducedriskofalzheimersdisease